2012
DOI: 10.1159/000337352
|View full text |Cite
|
Sign up to set email alerts
|

An Exonic <b><i>Peroxisome Proliferator-Activated Receptor-</i></b>γ<b><i> Coactivator-1</i></b>α Variation May Mediate the Resting Energy Expenditure through a Potential Regulatory Role on Important Gene Expression in This Pathway

Abstract: Background/Aims: We studied peroxisome proliferator-activated receptor-γ coactivator-1α (PPARGC1A) gene variations at the 23815227–23815706 positions and examined their possible correlation with obesity-related conditions and resting energy expenditure (REE). We investigated the expression of PPARGC1A, mitogen-activated protein kinase (MAPK) and uncoupling protein 2 (UCP2), which play key roles in cellular energy expenditure, in a cellular model consisting of peripheral blood mononuclear cells, and compared th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
14
2

Year Published

2014
2014
2022
2022

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 83 publications
2
14
2
Order By: Relevance
“…Moreover, the downregulation of SIRT3 plays an important role in increased serine and decreased tyrosine phosphorylation of the insulin receptor substrate (IRS), and decreased insulin signaling (Jing et al, ). Besides this, in line with our findings, previous studies suggested that PPARGC1A polymorphisms could have an effect on total cholesterol and low‐density lipoprotein cholesterol (Mirzaei et al, ). Therefore, our results are strengthened by the fact that the participants with T (rs2970847) and A‐deletion (rs11290186) allele carrier genotypes, with decreased PPARGC1A performance, are at a higher risk of obesity, diabetes, and cardiovascular disease.…”
Section: Discussionsupporting
confidence: 93%
“…Moreover, the downregulation of SIRT3 plays an important role in increased serine and decreased tyrosine phosphorylation of the insulin receptor substrate (IRS), and decreased insulin signaling (Jing et al, ). Besides this, in line with our findings, previous studies suggested that PPARGC1A polymorphisms could have an effect on total cholesterol and low‐density lipoprotein cholesterol (Mirzaei et al, ). Therefore, our results are strengthened by the fact that the participants with T (rs2970847) and A‐deletion (rs11290186) allele carrier genotypes, with decreased PPARGC1A performance, are at a higher risk of obesity, diabetes, and cardiovascular disease.…”
Section: Discussionsupporting
confidence: 93%
“…The accuracy of anthropometric measurements of height/waist and weight were 0.1 cm and 100 g, respectively. Complete body composition analysis was explained previously [24]. Body composition analyzer BC-418MA-Tanita (United Kingdom) was used to calculate the participant’s body composition [25] including weight, fat mass, fat-free mass, body fat percentage, muscle mass, visceral fat mass, abdominal fat mass.…”
Section: Methodsmentioning
confidence: 99%
“…Complete body composition analysis was described previously [24]. We assessed total body composition of subjects using a BC-418MA body composition analyzer (Illinois, USA).…”
Section: Complete Body Composition Analysismentioning
confidence: 99%